Division of Abbott Laboratories Inc.
Latest From CardioMEMS Inc.
The warning letter highlights validation and recordkeeping problems at the Atlanta manufacturing facility for the CardioMEMS heart failure remote monitoring system, but it is not expected to affect device availability.
Improving outcomes, reducing costs, and cutting readmissions are front and center for St. Jude Medical as it moves into new areas of cardio technology that suit the changing needs of both providers and patients.
A growing number of medical research institutions are investing in start-ups as a venture capitalist would, at times in new companies that have only tangential ties to the home institution.
Healthy market growth, the biggest ever M&A deal, a record number of billion-dollar takeovers, and the IPO market in impressive bounce-back…2014 was a year of superlatives for the global medtech industry. But with more expected of manufacturers while health care spending remains in the doldrums and demand for care rises, the long-term medtech winners will be those who can forecast how and where to make an impact on both costs and patient outcomes.
- Diagnostic Equipment & Supplies
- Implantable Devices
- Monitoring Equipment & Devices
- Radiofrequency Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Abbott Laboratories Inc.
- Senior Management
Jay S Yadav, CEO
Daniel H Bauer, CFO
- Contact Info
Phone: (678) 651-2300
387 Technology Cir. NW
Atlanta, GA 30313
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.